Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Mehra

Showing results (291-300 of 347) with videos related to

Pageof 35
Sort By:
Cell|December 16, 2017
Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNAYasuyuki Hosono, Yashar S Niknafs, John R Prensner, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective StudiesWilliam C Jackson, Jessica Silva, Holly E Hartman, et al.
BJU International|February 1, 2017
Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional studyWilliam C Jackson, Neil B Desai, Ahmed E Abugharib, et al.
Cell|July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancerQianben Wang, Wei Li, Yong Zhang, et al.
Cell Reports. Medicine|October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibitionYu Chang, Xiaoju Wang, Jianzhang Yang, et al.
The Lancet. Oncology|March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysisLaila A Gharzai, Ralph Jiang, David Wallington, et al.
The American Journal of Surgical Pathology|July 28, 2022
Clinicopathologic Spectrum of Secondary Solid Tumors of the Prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 CasesAndres M Acosta, Jennifer B Gordetsky, Katrina Collins, et al.
European Urology|December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence PostprostatectomyDaniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
The Journal of Urology|August 29, 2018
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone TherapyAlejandro Berlin, Fabio Y Moraes, Noelia Sanmamed, et al.
Neoplasia (New York, N.Y.)|October 26, 2012
Role of transcriptional corepressor CtBP1 in prostate cancer progressionRui Wang, Irfan A Asangani, Balabhadrapatruni V S K Chakravarthi, et al.
Pageof 35

Showing results (291-300 of 347) with videos related to

Sort By:
Pageof 35
Cell|December 16, 2017
Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNAYasuyuki Hosono, Yashar S Niknafs, John R Prensner, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective StudiesWilliam C Jackson, Jessica Silva, Holly E Hartman, et al.
BJU International|February 1, 2017
Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional studyWilliam C Jackson, Neil B Desai, Ahmed E Abugharib, et al.
Cell|July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancerQianben Wang, Wei Li, Yong Zhang, et al.
Cell Reports. Medicine|October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibitionYu Chang, Xiaoju Wang, Jianzhang Yang, et al.
The Lancet. Oncology|March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysisLaila A Gharzai, Ralph Jiang, David Wallington, et al.
The American Journal of Surgical Pathology|July 28, 2022
Clinicopathologic Spectrum of Secondary Solid Tumors of the Prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 CasesAndres M Acosta, Jennifer B Gordetsky, Katrina Collins, et al.
European Urology|December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence PostprostatectomyDaniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
The Journal of Urology|August 29, 2018
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone TherapyAlejandro Berlin, Fabio Y Moraes, Noelia Sanmamed, et al.
Neoplasia (New York, N.Y.)|October 26, 2012
Role of transcriptional corepressor CtBP1 in prostate cancer progressionRui Wang, Irfan A Asangani, Balabhadrapatruni V S K Chakravarthi, et al.
Pageof 35